Login
Home
Charts
Search
Watchlist
Products

Morepen Laboratories Ltd

MOREPENLAB·NSE
₹122.35+2.78%Wed, 23 Sept '26 15:31
Industry:Pharma - API & CRAMS
Indices:

Morepen Laboratories Ltd

MOREPENLAB
NSE
₹122.35
+2.78%
|Wed, 23 Sept '26 15:31
SOICxStockScans Reports
Industry
Pharma - API & CRAMS
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹6,711Cr
Close
Close Price
₹122.48
Industry
Industry
Pharma - API & CRAMS
PE
Price To Earnings
47.84
PS
Price To Sales
3.44
Revenue
Revenue
₹1,951Cr
Rev Gr TTM
Revenue Growth TTM
9.49%
PAT Gr TTM
PAT Growth TTM
50.75%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
422445423455438453466425412484485570
Growth YoY
Revenue Growth YoY%
4.727.616.313.53.81.910.1-6.6-6.06.94.034.1
Expenses
ExpensesCr
388394375404394417424401381438460488
Operating Profit
Operating ProfitCr
345148524436422431462483
OPM
OPM%
8.011.411.411.310.18.09.15.77.59.65.014.5
Other Income
Other IncomeCr
3443555430485
Interest Expense
Interest ExpenseCr
021111544445
Depreciation
DepreciationCr
8810625169111068
PBT
PBTCr
294442484635261646352375
Tax
TaxCr
71213121195458818
PAT
PATCr
213229363527201141281656
Growth YoY
PAT Growth YoY%
34.5255.8248.8147.263.9-16.6-29.3-68.517.83.0-22.7393.9
NPM
NPM%
5.07.26.88.08.05.94.42.710.05.73.29.9
EPS
EPS₹
0.40.60.50.70.70.50.30.20.80.50.31.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
422445423455438453466425412484485570
Growth YoY
Revenue Growth YoY%
4.727.616.313.53.81.910.1-6.6-6.06.94.034.1
Expenses
ExpensesCr
388394375404394417424401381438460488
Operating Profit
Operating ProfitCr
345148524436422431462483
OPM
OPM%
8.011.411.411.310.18.09.15.77.59.65.014.5
Other Income
Other IncomeCr
3443555430485
Interest Expense
Interest ExpenseCr
021111544445
Depreciation
DepreciationCr
8810625169111068
PBT
PBTCr
294442484635261646352375
Tax
TaxCr
71213121195458818
PAT
PATCr
213229363527201141281656
Growth YoY
PAT Growth YoY%
34.5255.8248.8147.263.9-16.6-29.3-68.517.83.0-22.7393.9
NPM
NPM%
5.07.26.88.08.05.94.42.710.05.73.29.9
EPS
EPS₹
0.40.60.50.70.70.50.30.20.80.50.31.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4855956077698531,1881,5471,4181,6901,8121,8061,951
Growth
Revenue Growth%
21.122.81.926.711.039.330.2-8.419.37.2-0.39.5
Expenses
ExpensesCr
4245345427017851,0701,4101,3381,5321,6381,6801,767
Operating Profit
Operating ProfitCr
626165686911913780159174126184
OPM
OPM%
12.710.310.78.88.010.08.85.69.49.67.09.4
Other Income
Other IncomeCr
144491210614184748
Interest Expense
Interest ExpenseCr
1184222-72481617
Depreciation
DepreciationCr
353434403730282833293636
PBT
PBTCr
13243029399912756135155120179
Tax
TaxCr
000061251739372438
PAT
PATCr
132430293497102399711896141
Growth
PAT Growth%
497.584.626.0-3.116.4189.14.7-62.0149.822.1-18.950.8
NPM
NPM%
2.64.04.93.83.98.26.62.75.76.55.37.2
EPS
EPS₹
0.30.50.70.60.82.22.30.81.92.21.72.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4855956077698531,1881,5471,4181,6901,8121,8061,951
Growth
Revenue Growth%
21.122.81.926.711.039.330.2-8.419.37.2-0.39.5
Expenses
ExpensesCr
4245345427017851,0701,4101,3381,5321,6381,6801,767
Operating Profit
Operating ProfitCr
626165686911913780159174126184
OPM
OPM%
12.710.310.78.88.010.08.85.69.49.67.09.4
Other Income
Other IncomeCr
144491210614184748
Interest Expense
Interest ExpenseCr
1184222-72481617
Depreciation
DepreciationCr
353434403730282833293636
PBT
PBTCr
13243029399912756135155120179
Tax
TaxCr
000061251739372438
PAT
PATCr
132430293497102399711896141
Growth
PAT Growth%
497.584.626.0-3.116.4189.14.7-62.0149.822.1-18.950.8
NPM
NPM%
2.64.04.93.83.98.26.62.75.76.55.37.2
EPS
EPS₹
0.30.50.70.60.82.22.30.81.92.21.72.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
90909090909096102102110110
Reserves
ReservesCr
911061361631942914576517451,0471,137
Current Liabilities
Current LiabilitiesCr
167325340339351404456321402501490
Non Current Liabilities
Non Current LiabilitiesCr
57182023283036374490199
Total Liabilities
Total LiabilitiesCr
5245385866156638581,0701,1111,2931,7781,936
Current Assets
Current AssetsCr
1571922432993725277347568891,1591,164
Non Current Assets
Non Current AssetsCr
367346342316291331336354404619773
Total Assets
Total AssetsCr
5245385866156638581,0701,1111,2931,7781,936
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
90909090909096102102110110
Reserves
ReservesCr
911061361631942914576517451,0471,137
Current Liabilities
Current LiabilitiesCr
167325340339351404456321402501490
Non Current Liabilities
Non Current LiabilitiesCr
57182023283036374490199
Total Liabilities
Total LiabilitiesCr
5245385866156638581,0701,1111,2931,7781,936
Current Assets
Current AssetsCr
1571922432993725277347568891,1591,164
Non Current Assets
Non Current AssetsCr
367346342316291331336354404619773
Total Assets
Total AssetsCr
5245385866156638581,0701,1111,2931,7781,936

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
504163171151-60-91733233
Investing Cash Flow
Investing Cash FlowCr
-27-14-27-13-12-70-32-47-83-322-123
Financing Cash Flow
Financing Cash FlowCr
-27-24-38054766144530097
Net Cash Flow
Net Cash FlowCr
-43-14428-266-5107
Free Cash Flow
Free Cash FlowCr
4131539-629-106-1272-92-52
CFO To PAT
CFO To PAT%
391.2172.3213.060.232.852.4-59.2-235.775.927.234.1
CFO To EBITDA
CFO To EBITDA%
81.366.398.025.716.142.9-44.1-114.646.318.426.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
504163171151-60-91733233
Investing Cash Flow
Investing Cash FlowCr
-27-14-27-13-12-70-32-47-83-322-123
Financing Cash Flow
Financing Cash FlowCr
-27-24-38054766144530097
Net Cash Flow
Net Cash FlowCr
-43-14428-266-5107
Free Cash Flow
Free Cash FlowCr
4131539-629-106-1272-92-52
CFO To PAT
CFO To PAT%
391.2172.3213.060.232.852.4-59.2-235.775.927.234.1
CFO To EBITDA
CFO To EBITDA%
81.366.398.025.716.142.9-44.1-114.646.318.426.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,1748551,3887764291,4461,7491,3132,1502,6221,8526,711
Price To Earnings
Price To Earnings
93.235.946.726.912.714.917.233.822.422.319.547.8
Price To Sales
Price To Sales
2.41.42.31.00.51.21.10.91.31.41.03.4
Price To Book
Price To Book
6.54.46.23.11.53.83.21.72.52.31.55.4
EV To EBITDA
EV To EBITDA
19.713.821.411.25.911.812.616.113.415.415.837.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.636.136.532.632.232.329.729.332.730.931.831.8
OPM
OPM%
12.710.310.78.88.010.08.85.69.49.67.09.4
NPM
NPM%
2.64.04.93.83.98.26.62.75.76.55.37.2
ROCE
ROCE%
10.315.814.911.813.925.220.97.415.913.09.49.4
ROE
ROE%
7.112.013.211.411.825.518.45.111.410.27.77.7
ROA
ROA%
2.44.45.14.75.111.39.53.57.56.64.94.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1,1748551,3887764291,4461,7491,3132,1502,6221,8526,711
Price To Earnings
Price To Earnings
93.235.946.726.912.714.917.233.822.422.319.547.8
Price To Sales
Price To Sales
2.41.42.31.00.51.21.10.91.31.41.03.4
Price To Book
Price To Book
6.54.46.23.11.53.83.21.72.52.31.55.4
EV To EBITDA
EV To EBITDA
19.713.821.411.25.911.812.616.113.415.415.837.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.636.136.532.632.232.329.729.332.730.931.831.8
OPM
OPM%
12.710.310.78.88.010.08.85.69.49.67.09.4
NPM
NPM%
2.64.04.93.83.98.26.62.75.76.55.37.2
ROCE
ROCE%
10.315.814.911.813.925.220.97.415.913.09.49.4
ROE
ROE%
7.112.013.211.411.825.518.45.111.410.27.77.7
ROA
ROA%
2.44.45.14.75.111.39.53.57.56.64.94.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Morepen Laboratories Ltd

  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/llckzo9gjb43kj6bbj7605c2.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/gseevzs723khms0c6ok3q8rk.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/y78jzukm1xf3z91zhms9wir5.pdf
  • Q1 FY2025 Earnings Call Transcript (Jun 2024, PDF): https://www.stockscans.in/document/by214m8npf3f7aq1bfxw9sx5.pdf
  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/0pusyx8755drdlt736a0ym45.pdf
  • Q3 FY2024 Earnings Call Transcript (Dec 2023, PDF): https://www.stockscans.in/document/9fkwyd2k8evldphglzby4jal.pdf
  • Q2 FY2024 Earnings Call Transcript (Sep 2023, PDF): https://www.stockscans.in/document/kylbuseavxl4zm3ulh7dsi7v.pdf
  • Q4 FY2022 Earnings Call Transcript (Mar 2022, PDF): https://www.stockscans.in/document/5apojet30j0g4gwa30wd5g9n.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/58vhzdsztlygcv49z7n9eqvf.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/h1ki59072g0pwzhsbkuxkgs4.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/nrjarv3q20qphrm6eujo5b23.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/gd7yqb6jbslap0fjkdgbekxp.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/uheo35hofs2g89nkqh7hqtup.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/p7i4x9x0q0luixqphhtmsb0p.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/dsucq3ip5rofs5ap04xt4ogc.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/1yzast0w0cxrg9ylk0s62pjv.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/yu0dyoc3wu9kblf1ge4ae5jn.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/iunvw5uxaxbagtv468m2p0pg.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/n8jkxgggarulqk3q1dqskf8u.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/mewqjpqsjdxx840jcsjj1f1x.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/hy6lesaj7oynfiimr2402tbk.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/pxxol7vq4w2tl4sym0naotrm.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/oh68uzq9kag1mkre88v1gx2j.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/xovcq0aoengfcfe3fi4gs0b4.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/fmyl4mpq1pkcbtlm610mpick.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/rbxgj2yh13eyb3uospdphy9h.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/oqtn5s1rbhr5a316m9cnert1.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/1yytlfu0jv2lfzyln4ku5k9i.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/3wte9shgbl3rc6j7py4qvbyg.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/72gb4nk839smzd56ev9zf97k.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/etq42ye4cd1h9grh0u7ymh96.pdf

Concall Transcript Summaries — Morepen Laboratories Ltd

  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AMOREPENLAB/transcript-notes/202503/llckzo9gjb43kj6bbj7605c2.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AMOREPENLAB/transcript-notes/202412/gseevzs723khms0c6ok3q8rk.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AMOREPENLAB/transcript-notes/202409/y78jzukm1xf3z91zhms9wir5.pdf
  • Q1 FY2025 Concall Transcript Summary (Jun 2024): https://www.stockscans.in/company/NSE%3AMOREPENLAB/transcript-notes/202406/by214m8npf3f7aq1bfxw9sx5.pdf
  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3AMOREPENLAB/transcript-notes/202403/0pusyx8755drdlt736a0ym45.pdf
  • Q3 FY2024 Concall Transcript Summary (Dec 2023): https://www.stockscans.in/company/NSE%3AMOREPENLAB/transcript-notes/202312/9fkwyd2k8evldphglzby4jal.pdf
  • Q2 FY2024 Concall Transcript Summary (Sep 2023): https://www.stockscans.in/company/NSE%3AMOREPENLAB/transcript-notes/202309/kylbuseavxl4zm3ulh7dsi7v.pdf
  • Q4 FY2022 Concall Transcript Summary (Mar 2022): https://www.stockscans.in/company/NSE%3AMOREPENLAB/transcript-notes/202203/5apojet30j0g4gwa30wd5g9n.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies